Propanc Biopharma, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $29 |
Gross Profit | -6 | -6 | -3 | 14 |
EBITDA | -6,315 | -3,026 | -4,528 | -3,811 |
EBIT | -6,322 | -3,032 | -4,532 | -3,816 |
Net Income | -6,360 | -3,091 | -4,837 | -4,071 |
Net Change In Cash | 0 | 0 | 0 | 29 |
Free Cash Flow | -1,137 | -1,006 | -1,941 | -27 |
Cash | 443 | 561 | 602 | 12 |
Basic Shares | 897 | 534 | 12,331 | 11,611 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -21 | -17 | -5 | |
EBITDA | -58,339 | -1,262 | -2,235 | -2,139 |
EBIT | -58,359 | -1,283 | -2,257 | -2,140 |
Net Income | -58,923 | -1,821 | -2,661 | -2,658 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -405 | -935 | -1,105 | -1,436 |
Cash | 12 | 21 | 10 | 4 |
Basic Shares | 3,968 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.39 |
2025-06-30 | -$0.35 |
2025-03-31 | -$12.50 |
2024-12-31 | -$67.65 |